GCP Training for Clinical Trials
Investigators involved in the conduct, oversight, or management of clinical trials are required to complete training in Good Clinical Practice (GCP). The NIH Office of Science Policy has more information regarding the GCP training policy. The GCP training is an additional requirement and does not replace the Protections of Human Participants training.
The CITI program offers three courses:
- GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus);
- GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus); and
- GCP – Social and Behavioral Research Best Practices for Clinical Research.
Review the options below and complete the course most applicable to your research:
GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus)
Suitable for individuals proposing to conduct clinical trials of drugs and devices primarily in the U.S. and/or who would prefer a more U.S. FDA-centric curriculum.
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
Suitable for individuals involved in clinical trials of drugs and biologics when the research may be international or where the individuals would prefer a more ICH-focused curriculum.
GCP - Social and Behavioral Research Best Practices for Clinical Research
Suitable for individuals involved in clinical trials using behavioral interventions and social science research.
Please learn more about the GCP training and available options, visit the CITI Program Good Clinical Practice website.
To take the GCP training, for MIT Faculty, staff, or students: Please log into the CITI site via the MIT portal. You will need a valid MIT certificate in order to get access.
For non MIT personnel: Please log into the University of Miami CITI site. When registering for the course, select 'Massachusetts Institute of Technology - Affiliates' as your institution.